InspireMD (NSPR) Restructuring Costs (2015 - 2025)
InspireMD's (NSPR) quarterly Restructuring Costs came in at $1.3 million in Q4 2025, up 21.29% year-on-year from $1.1 million in Q4 2024, and down 29.02% quarter-over-quarter from $1.8 million in Q3 2025.
InspireMD (NSPR) Restructuring Costs (2015 - 2025) Analysis & Trends
InspireMD's Restructuring Costs history runs 3 years deep, the most recent figure standing at $1.3 million for Q4 2025.
- On a quarterly basis, Restructuring Costs rose 21.29% year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $6.3 million, a 38.12% increase from a year earlier, with the FY2025 full-year figure at $6.4 million, up 37.72% from the prior year.
- Restructuring Costs retreated to $1.3 million in Q4 2025 per NSPR's latest filing, from $1.8 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $1.8 million in Q3 2025 and bottomed at $1.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn |
| 10 | InspireMD | 43.81 Mn | -10.41 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2015 | 18,000.00 |
| Sep 30, 2015 | 418,000.00 |
| Jun 30, 2015 | 32,000.00 |